Ziftomenib 200 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 200 mg
Reference Brands: Komzifti (USA)
Category: Oncology Cancer Care
Ziftomenib is a small‑molecule menin inhibitor. It blocks the interaction between menin and MLL proteins, disrupting a pathway critical for the survival and proliferation of certain leukemia cells, especially those with NPM1 mutation or MLL rearrangement. It is used in adult patients with relapsed or refractory AML who have no satisfactory alternative treatment options.
Ziftomenib — third party manufacturing & bulk supply
Ziftomenib 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ziftomenib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ziftomenib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ziftomenib →Frequently Asked Questions
Ziftomenib is used to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have an NPM1 mutation and have no satisfactory alternative treatment options. It works by targeting the genetic pathway driving the leukemia to slow disease progression.
It is made from the active pharmaceutical ingredient ziftomenib, a small-molecule menin inhibitor that disrupts the interaction between the Menin protein and KMT2A (MLL), which helps prevent the growth of leukemia cells.
The trade name is Komzifti.
Komzifti is manufactured by Kura Oncology in collaboration with Kyowa Kirin.
The generic name is ziftomenib.
The brand name is Komzifti.
It is manufactured in approved pharmaceutical facilities in the USA and Japan, with distribution depending on regulatory approvals.
Related Products
Lanreotide
Strength:
60 mg, 90 mg, 120 mg
Form: Injection
Reference Brands: omatuline Depot (USA), Somatuline Autogel (USA)
View Details
Clofarabine
Strength:
1 mg/mL
Form: Injection
Reference Brands: Clolar (USA), Evoltra (EU/UK)
View Details
Quick Response Guaranteed | Verified Suppliers
